Smart Medical Devices Market Is Projected To Grow At A CAGR Of Over 24.0% From 2016 To 2025

Global Smart Medical Devices Market is expected to reach USD 24.46 billion by 2025, according to a new report by Grand View Research, Inc. The increasing adoption of smartphones is observed as a major factor driving market growth. In addition, the technological advancement and the rising awareness and focus on fitness is driving the market.

The increasing demand for wireless and smartphone compatible devices which is enhancing the diagnosis and makes accurate detection is making it convenient for patients to monitor their health anywhere and save the result on the connected device, is additionally driving the market.

Diagnostic and monitoring segment was the largest product category in 2015, but is expected to register a lower growth as compared to the therapeutic segment over the forecast period. Blood pressure monitor was the major diagnostic and monitoring device used by the patients in 2015 and accounts for a share of over 20.0% in 2015.

Online channel is the largest shareholder with an estimated CAGR of about 22.0% from 2016 to 2025. The trending online purchase for discounts, flexibility, convenience and availability of wide range of products with varying prices is leading to demand for purchasing smart medical devices online Additionally, the use of smartphones is expected the boost the market.

Full Research Report on Global Smart Medical Devices Market Analysis:
http://www.grandviewresearch.com/industry-analysis/smart-medical-devices-market

Further key findings from the report suggest:

• The global smart medical devices witnessed a lucrative growth in 2015 and is expected to grow at a CAGR of over 20.0% from 2016 to 2025
• Diagnostic and monitoring segment emerged as the largest product segment in 2015 and is estimated to generate revenue over USD 8.0 billion by 2025
• The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies. The regional market is expected to grow at a CAGR of over 20.0% from 2016 to 2025
• Key players including Abbott Laboratories, Apple Inc, Dexcom Inc, Fitbit Inc and Medtronic plc among the others dominate the global smart medical devices market while accounting for majority of the volume in 2015

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Smart Medical Devices Market on the basis of product, distribution channel, end-use, and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)

• Diagnostic & monitoring
• Blood glucose monitors
• Heart rate monitors
• Pulse oximeters
• Blood pressure monitors
• Breath analyzer
• Medical tricorder
• Smart clothing
• Therapeutic devices
• Portable oxygen concentrators and ventilators
• Insulin pumps
• Hearing aid
• Others

Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)

• Pharmacies
• Online channel
• Others

End-user Outlook (Revenue, USD Million, 2014 - 2025)

• Hospitals
• Clinics
• Homecare
• Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East Asia
• South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-smart-medical-devices-market           

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Urodynamic Equipment And Consumables Market Is Anticipated To Grow At A CAGR Of 6.32% Throughout The Forecast Period 2014-2025

Global Urodynamic Equipment And Consumables Market is expected to reach USD 335.40 million by 2025, according to a new report by Grand View Research, Inc. This market is anticipated to grow at an unprecedented rate owing to growing geriatric population that exhibits greater vulnerability to urological dysfunctions. In addition, unprecedented upsurge in prevalence of bladder cancer poses high clinical urgency to adopt highly efficient diagnostics, which thereby broadens future growth prospects. In 2017, as per the American Cancer Society, bladder cancer accounted for 5.0% of all cancers in the U.S.

The market is also driven by global increase in obesity. As per the Centers for Disease Control and Prevention, approximately 36.0% of adult population is obese. According to a research published in NCBI, obesity has increased the risk of developing various urological conditions, such as prostate cancer, nephrolithiasis, hypogonadism, and urinary tract infections. Furthermore, expanding network of testing centers for urological diseases is also broadening growth prospects. Prominent players are engaging in strategic collaboration and acquisitions to increase their geographical presence. For instance, in September 2016, Brighter Health Network LLC announced the acquisition of Urodynamic Testing Specialists to geographically expand in to Florida and the Northeastern region of the U.S.

Full Research Report on Global Urodynamic Equipment And Consumables Market Analysis:
http://www.grandviewresearch.com/industry-analysis/smart-meters-market

Further Key Findings From the Report Suggest:

• Uroflowmetry equipment held the largest share in the type segment in 2016. This can be attributed to its adoption in testing a wide range of indications such as urinary blockage, bladder dysfunction, prostate cancer, benign prostatic hypertrophy, and others
• Ambulatory urodynamic equipment is expected to grow at a lucrative rate owing to associated benefits such as greater availability & portability and higher efficiency in comparison with conventional methods
• North America accounted fora substantial share owing to increasing number of supportive government initiatives and high awareness amongst end-users
• Asia Pacific is expected to witness exponential CAGR during the forecast period owing to high burden of target diseases and continual infrastructure upgradation of urological testing centers
• Major players are creating a highly competitive atmosphere by adopting strategies such as new product development, collaborations, and strategic agreements
• For instance, in July 2016, LABORIE announced the addition of urology and gastroenterology product portfolio of Medical Measurement Systems B.V.to its existing line of products

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Urodynamic Equipment And Consumables Market on the basis of type and region:

Urodynamic Equipment and Consumables Type Outlook (Revenue, USD Million, 2014 - 2025)

• Uroflowmetry Equipment
• Cystometer
• Ambulatory Urodynamic Systems
• Electromyographs
• Video Urodynamic Systems
• Urodynamic Consumables
• Urodynamic Catheters
• Urodynamic Pumps and Transducer Sets

Urodynamic Equipment and Consumables Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-urodynamic-equipment-consumables-market          

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Drug And Gene Delivery Systems Market Report Covers Revenue Forecast, Company Share, Competitive Landscape, Growth Factors And Trends 2014-2025

Global Drug And Gene Delivery Systems Market is expected to reach USD 786.9 Billion by 2025, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.

Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.

Full Research Report On Global Drug and Gene Delivery Systems Market Analysis: http://www.grandviewresearch.com/industry-analysis/drug-gene-delivery-devices-market

Further key findings from the study suggest:

• The market study suggests that oral segment dominated the market in 2015
• The convenience of use and low manufacturing cost are the prime factors responsible for the dominance of the oral delivery segment
• Injectable segment is expected to show a lucrative growth rate owing to the introduction of technically advanced injecting devices that enable convenient self-injection
• North America dominated the market in 2015 and is expected to remain dominant throughout the forecast period owing to highly developed healthcare infrastructure and high healthcare spending
• Asia pacific is expected to exhibit the fastest growth rate during the forecast period owing to the factors such as rapidly developing economies, growing disposable income, and high adaption of the advanced delivery systems
• A few of the major market players in drug delivery systems space are F. Hoffmann-La Roche Ltd, Pfizer, Inc., Johnson and Johnson private Ltd, Novartis AG, Becton, Dickinson and Company, and Bayer AG.
• Major market players in the gene delivery systems space are SiBiono GeneTech Co., Unique N.V., Epeius Biotechnologies Corporation, Human Stem Cells Institute, and Shanghai Sunway Biotech Co., Ltd.

View all Related Reports from Same Category: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Drug And Gene Delivery Systems Market on the basis of route of administration, vectors, methods, and region:

Route of Administration Outlook (Revenue, USD Billion, 2014 - 2025)

• Oral
• Inhalation
• Transdermal
• Injectable
• Ocular
• Nasal
• Topical

Vector Outlook (Revenue, USD Million, 2014 - 2025)

• Viral
• Non-viral

Method Outlook (Revenue, USD Million, 2014 - 2025)

• In situ
• Ex vivo

Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• U.S. Drug Delivery Systems Market, by Route of Administration
• U.S. Gene Delivery Systems Market, by Vectors
• U.S. Gene Delivery Systems Market, by Method
• Canada Drug Delivery Systems Market, by Route of Administration
• Canada Gene Delivery Systems Market, by Vectors
• Canada Gene Delivery Systems Market, by Method
•  Europe
• UK Drug Delivery Systems Market, by Route of Administration
• UK Gene Delivery Systems Market, by Vectors
• UK Gene Delivery Systems Market, by Method
• Germany Drug Delivery Systems Market, by Route of Administration
• Germany Gene Delivery Systems Market, by Vectors
• Germany Gene Delivery Systems Market, by Method
• Asia Pacific
• Japan Drug Delivery Systems Market, by Route of Administration
• Japan Gene Delivery Systems Market, by Vectors
• Japan Gene Delivery Systems Market, by Method
• China Drug Delivery Systems Market, by Route of Administration
• China Gene Delivery Systems Market, by Vectors
• China Gene Delivery Systems Market, by Method
• Latin America
• Brazil Drug Delivery Systems Market, by Route of Administration
• Brazil Gene Delivery Systems Market, by Vectors
• Brazil Gene Delivery Systems Market, by Method
• Mexico Drug Delivery Systems Market, by Route of Administration
• Mexico Gene Delivery Systems Market, by Vectors
• Mexico Gene Delivery Systems Market, by Method
•  MEA
• South Africa Drug Delivery Systems Market, by Route of Administration
• South Africa Gene Delivery Systems Market, by Vectors
• South Africa Gene Delivery Systems Market, by Method

View Press Release of this Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-drug-gene-delivery-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Dodecanedioic Acid (DDDA) Market Analysis By Application, Bio-based Potential And Segment Forecasts Up To 2022

Global Dodecanedioic Acid (DDDA) Market is expected to reach USD 443.3 million by 2022, according to a new study by Grand View Research, Inc. Increasing demand for nylon 6,12 from various end-use industries including polymers, detergents and coatings is expected to drive DDDA market growth over the forecast period. In addition, increasing paints & coatings production is likely to fuel DDDA demand. Development of new coating technologies for the industrial paints has contributed to the growth of DDDA on account of its ability to resist corrosion and provide durable flexible coatings.

Penetration of DDDA in resin applications was highest in 2014, as it is used as a key raw material for manufacturing nylon. Increasing consumption of nylon 6,12 in automotive, electrics & electronics and construction is likely to drive DDDA market production. Growth of these end-use industries is anticipated to subsequently impact market growth in resin applications over the forecast period.

Full Research Report On Global Dodecanedioic Acid (DDDA) Market Analysis:http://www.grandviewresearch.com/industry-analysis/dodecanedioic-acid-ddda-industry

Further key findings from the study suggest:

• Asia Pacific was the largest market for DDDA accounting for over 35% of the global volume share in 2014 owing to the presence of a robust industrial base in the region. High potential for industrialization in the region is expected to drive demand for DDDA over the forecast period, making it a high growth market. Discovery of shale gas in the U.S. is expected to open new opportunities in lubricant applicatios in North America in the near future.
• China was the largest producer and consumer of DDDA owing to the presence of a robust polymer and paint & coatings manufacturing base in the country. China accounted for over 25% of the global market volume in 2014 and is expected to maintain its lion’s share over the forecast period.
• Global DDDA demand in adhesives was 3.3 kilo tons in 2014 and is expected to grow at a CAGR of over 5% from 2015 to 2022. Rising importance of high performance adhesives in industrial applications has resulted in growing demand for adhesives. Growth of major end use industries such as construction and automotive, mainly in countries such as China, India and Brazil is expected to drive the global adhesives and sealants market over the next six years.
• Key players present in the global lignin market include Ube, Cathay Industrial Biotech, Verdezyne Inc., Evonik Industries AG, Invista and Santa Cruz Biotechnology Inc. the global industry is characterized by integration by numerous companies across various stages of the value chain. Verdezyne has established a bio-based DDDA plant in Malaysia and as per the company’s outlook, their plant can replace 30% of the global synthetic market.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/renewable-chemicals

For the purpose of this study, Grand View Research has segmented the Global Dodecanedioic Acid (DDDA) Market on the basis of application and region:

Global DDDA Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

• Resins
• Powder coatings
• Adhesives
• Lubricants
• Others

Global DDDA Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

• North America
• U.S.
• Europe
• Germany
• UK
• Latin America
• Asia Pacific
• China
• India
• MEA

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-dodecanedioic-acid-market

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

DNA Testing Market Analysis By Technology, Application And segment Forecast Up To 2022

Global DNA Testing Market is anticipated to reach USD 10.04 billion by 2022, according to a new study by Grand View Research Inc. Rise in developments in the field of genome sequencing and personalized DNA level diagnostic applications, a considerable growth in the number of patented research initiatives by the government and government funded projects are factors expected to drive demand during the forecast period.

Introduction of novel technologies for genome profiling are expected to boost progress of this industry over the forecast period. Furthermore, increasing incidences of chronic oncology and infectious diseases that depend on DNA prototyping for treatment and diagnosis using personalized medicine are anticipated to significantly raise demand for DNA diagnostics/testing based research thereby propelling industrial growth in the coming years. Increasing demand for prenatal testing and in-vitro fertilization that subsequently leads to rise in demand for DNA diagnostics/testing is also attributive towards expected progress in this market.

Full Research Report on Global DNA Testing Market Analysis: http://www.grandviewresearch.com/industry-analysis/dna-testing-market

Further key findings from the study suggest:

• PCR based diagnosis accounted for the largest share of the market revenue in 2014 as a result of higher preference rate coupled with higher availability of products and reagent kits of this segment.
• Next generation sequencing application for DNA testing is estimated to witness significant progress with a double digit CAGR of over 16% amongst the other technology segments due to presence of significant advantages offered by this technique of DNA identification and testing.
• Infectious disease diagnostics accounted for the largest market share in 2014 due to higher incidence rate of various infectious disorders which subsequently raises the demand for in-vitro nucleic acid based diagnostic tests for diagnosis and monitoring of disease progression.
• There are diverse applications of DNA testing market out of which oncology diagnostics and histopathology is estimated to register lucrative growth over the forecast period. Factors attributing for considerable growth potential in this segment include identification of cancer causing genes & associated research, and facilitation in mutation detection
• North America dominated the market in 2014, with revenue estimated at over USD 2,600 million. Presence of sophisticated healthcare infrastructure, rising incidence of genetic abnormalities, favorable government initiatives with respect to genetic diagnosis and its application in in-vitro fertilization are major factors driving growth of this region.
• Asia Pacific is anticipated to witness lucrative growth as a result of developments in health care infrastructure in this region coupled with presence of significant number of target population that is suffering with chronic as well as acute disorders. Government initiatives taken up herein are also attributive to influence sector growth to a great extent.
• Key participants of DNA testing industry include Abbott Laboratories, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Applied Biosystems Group, Cepheid Inc., Transgenomic Inc., Siemens Healthcare, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Alere Inc, Affymetrix Inc., Hologic, Dako, and 454 Life Sciences.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented DNA Testing Market on the basis of technology, application, and region:

 Global DNA Diagnostics/Testing Technology Outlook (Revenue, USD Million, 2012 - 2022)

• Microarrays based diagnostics
• PCR based diagnostics
• In-situ hybridization diagnostics
• NGS DNA diagnosis

Global DNA Diagnostics/Testing Application Outlook (Revenue, USD Million, 2012 - 2022)

• Prenatal DNA Carrier Screening
• Preimplantation Diagnosis
• Newborn Genetic Screening
• Infectious Disease Diagnostics
• HBV Diagnostic
• HCV Diagnostic
• HIV Diagnostic
• TB Diagnostic
• CT/NG Diagnostic
• HPV Diagnostic
• MRSA Diagnostic
• Others
• Oncology Diagnostics & Histopathology
• Identity Diagnostics & Forensics
• Pharmacogenomics Diagnostic Testing
• Drug Metabolism & P450 effects
• Others

DNA Diagnostics/Testing Regional Outlook (Revenue, USD Million, 2012 - 2022)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-dna-testing-market  

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Distributed Natural Gas-Fueled Generation Market Analysis By Technology, End-Use, And Segment Forecast Up To 2024

Global Distributed Natural Gas-Fueled Generation Market is expected to reach USD 32.21 Billion by 2024, according to a new report by Grand View Research, Inc. Increasing government initiatives to promote the use of natural gas as a generator fuel especially in emerging markets of China, and India is expected to boost the global market.  In addition, various benefits offered by DNGG, such as low carbon emissions, increasing natural gas usage, and other operational benefits,  are expected to steer the market growth over the forecast period.

There are huge investments in the power sector to develop the distributed generation technologies by emerging companies. At the same time, they are in need of high technologies, which will act as a substitute for current methods like diesel or coal generation.

The companies R&D facilities of hydrogen and fuel cell focuses on integrating, developing, and demonstrating hydrogen storage, delivery and production and also on using fuel cell technologies for stationary, transportation, and portable applications to differentiate their product from their competitor.

Full Research Report on Global Distributed Natural Gas-Fueled Generation Market Analysis:
http://www.grandviewresearch.com/industry-analysis/distributed-natural-gas-fueled-generation-market

Further key findings from the report suggest:

• Stationary fuel cells hold the largest CAGR of 13.1% in the global technology segment and are expected to grow at 6,116.8 million by 2024.
• Microturbines technology in Europe is estimated to be USD 3,964.8 million in 2015 and will witness the fastest growth in next seven years, growing at a CAGR of 12.2% over the forecast period. By integrating an innovating turbine engine, advanced power electronics, magnetic generator with fuel cell technology, the micro turbine can provide cleaner energy which will increase the DNGG market.
• Commercial and industrial accounted for around 67% of the global DNGG end-use segment in 2015 and is anticipated to reach 20,620.1 million by 2024, growing at an anticipated CAGR of 12% from 2016 to 2024.
• Europe accounted for 36% of the total market in 2015 and is anticipated to hold its leading position over the forecast period. Asia Pacific is anticipated to witness a high CAGR of over 13.1% over the forecast period. Increasing usage of DNGG in residential and commercial sector coupled with government initiatives mainly in China and India is expected to boost DNGG demand in the region.
• Key industry participants in the market includeCummins Inc., ShanDongLvhuan Power Equipment CO., LTD, MWM GmbH, ABB Group, Redox Power Systems, LLC, General Electric, and Plug Power Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/construction-and-utilities

Grand View Research has segmented the Global Natural Gas-Fueled Generation Market on the basis of technology, end-use and region:

Global Distributed Natural Gas-Fueled Generation Technology Outlook (Revenue, USD Million, 2014 - 2024)

• Natural Gas Gensets
• Stationary fuel cells
• Microturbines

Global Distributed Natural Gas-Fueled Generation End-Use Outlook (Revenue, USD Million, 2014 - 2024)

• Residential
• Building & institutional
• Commercial & industrial

Global Distributed Natural Gas-Fueled Generation Regional Outlook (Revenue, USD Million, 2014 - 2024)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Central & South America
• Middle East & Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-distributed-natural-gas-fueled-generation-market

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Peptide Therapeutics Market Is Expected To Grow At CAGR Of 9.4% Over The Forecast Period 2014-2025

Global Peptide Therapeutics Market is expected to reach USD 48.04 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for efficient & rapid-acting therapeutics for treatment of cancer and other lifestyle-associated disorders, which result in lesser adverse effects, are anticipated to propel market growth. 

Rising incidence of cancer calls for exploring and introducing other means of therapies and low-cost treatment alternatives. Moreover, growing base of geriatric population is expected to widen the consumer base by triggering incidence rate of target diseases such as cancer & diabetes, which are expected to drive the demand for peptide therapeutics.

Technological advancements in peptide manufacturing process is one of the major factors driving the market growth during the forecast period. Manufacturers and suppliers are focusing on the adoption of novel technologies to manufacture efficient drug molecules with low time and capital investment. Improvement in purification & automation process and less generation of waste is an additional factor attributing toward market growth

Full Research Report on Global Peptide Therapeutics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/peptide-therapeutics-market

Further Key Findings From the Study Suggest:

• Cancer held the largest market share in 2016 owing to increasing demand for alternative therapeutics over conventional treatment options. Peptides are being used as potential therapeutic agents in cancer treatment.
• The generic drug segment is expected to showcase upward shift due to patent expiration of blockbuster peptides and supportive government initiatives pertaining to the introduction of generic class
• Outsourced manufacturing is expected to grow at CAGR of 6.7% owing to requirements of complex procedures and shift in preference toward outsourcing, which helps in eliminating cost of production.
• Route of administration including nasal and intradermal routes is expected to grow at a rapid pace owing to ease of usage and advantages over other routes of administration such as oral.
• Hybrid technology is expected to spearhead the growth of this market. Benefits associated with this technology such as time conservation and ease of usage for both solid- and liquid-phase peptide synthesis are the key factors affirming growth.
• North America held the largest share in terms of revenue in 2016 owing to higher level of awareness pertaining to genomics & proteomics products, well-established R&D infrastructure, and rising funding initiatives
• Asia Pacific industry is expected to showcase lucrative growth over the forecast period with CAGR of 11.0%. Presence of established generic industry and API providers in this region coupled with growing economic stability in some of the countries is expected to propel market growth.
• Some of the key players in the peptide therapeutics market include Eli Lilly and Company; Pfizer, Inc.; Amgen, Inc.; Takeda Pharmaceutical Company Limited; Teva Pharmaceuticals Industries Ltd.; Lonza Inc.; Sanofi; Bristol-Myers Squibb (BMS); AstraZeneca PLC; GlaxoSmithKline plc (GSK); Novartis AG; and Novo Nordisk A/S

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Peptide Therapeutics Market by application, type, type of manufacturers, route of administration, synthesis technology, and region:

Peptide Therapeutics, Application Outlook (Revenue, USD Million; 2014 - 2025)

• Cancers
• Metabolic
• Cardiovascular Disorder
• Respiratory
• GIT
• Antiinfection
• Pain
• Dermatology
• CNS
• Renal
• Others

Peptide Therapeutics, Type Outlook (Revenue, USD Million; 2014 - 2025)

• Generic
• Innovative

Peptide Therapeutics, Type of Manufacturers Outlook (Revenue, USD Million; 2014 - 2025)

• In-house
• Outsourced

Peptide Therapeutics, Route of Administration Outlook (Revenue, USD Million; 2014 - 2025)

• Parenteral Route
• Oral Route
• Pulmonary
• Mucosal
• Others

Peptide Therapeutics, Synthesis Technology Outlook (Revenue, USD Million; 2014 - 2025)

• Solid Phase Peptide Synthesis (SPPS)
• Liquid Phase Peptide Synthesis (LPPS)
• Hybrid Technology

Peptide Therapeutics, Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-peptide-therapeutics-market             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com